|
1
|
Lee YS, Cheon IS, Kim BH, Kwon MJ, Lee HW
and Kim TY: Loss of extracellular superoxide dismutase induces
severe IL-23-mediated skin inflammation in mice. J Invest Dermatol.
133:732–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grayson M: Psoriasis. Nature. 492:S492012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balato N, Megna M, Di Costanzo L, Balato A
and Ayala F: Educational and motivational support service: a pilot
study for mobile-phone-based interventions in patients with
psoriasis. Br J Dermatol. 168:201–205. 2013. View Article : Google Scholar
|
|
4
|
Hirotsu C, Rydlewski M, Araújo MS, Tufik S
and Andersen ML: Sleep loss and cytokines levels in an experimental
model of psoriasis. PLoS One. 7:e511832012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Young MR and Colburn NH: Fra-1 a target
for cancer prevention or intervention. Gene. 379:1–11. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rauscher FJ III, Cohen DR, Curran T, Bos
TJ, Vogt PK, Bohmann D, Tjian R and Franza BR Jr: Fos-associated
protein p39 is the product of the jun proto-oncogene. Science.
240:1010–1016. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki T, Okuno H, Yoshida T, Endo T,
Nishina H and Iba H: Difference in transcriptional regulatory
function between c-Fos and Fra-2. Nucleic Acids Res. 19:5537–5542.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshioka K, Deng T, Cavigelli M and Karin
M: Antitumor promotion by phenolic antioxidants: inhibition of AP-1
activity through induction of Fra expression. Proc Natl Acad Sci
USA. 92:4972–4976. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bergers G, Graninger P, Braselmann S,
Wrighton C and Busslinger M: Transcriptional activation of the
fra-1 gene by AP-1 is mediated by regulatory sequences in the first
intron. Mol Cell Biol. 15:3748–3758. 1995.PubMed/NCBI
|
|
10
|
Schonthaler HB, Guinea-Viniegra J and
Wagner EF: Targeting inflammation by modulating the Jun/AP-1
pathway. Ann Rheum Dis. 70(Suppl 1): i109–i112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guinea-Viniegra J, Zenz R, Scheuch H,
Hnisz D, Holcmann M, Bakiri L, Schonthaler HB, Sibilia M and Wagner
EF: TNFalpha shedding and epidermal inflammation are controlled by
Jun proteins. Genes Dev. 23:2663–2674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wagner EF: Bone development and
inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis.
69:i86–i88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zenz R and Wagner EF: Jun signalling in
the epidermis: From developmental defects to psoriasis and skin
tumors. Int J Biochem Cell Biol. 38:1043–1049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johansen C, Kragballe K, Rasmussen M, Dam
TN and Iversen L: Activator protein 1 DNA binding activity is
decreased in lesional psoriatic skin compared with nonlesional
psoriatic skin. Br J Dermatol. 151:600–607. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oberprieler NG and Taskén K: Analysing
phosphorylation-based signalling networks by phospho flow
cytometry. Cell Signal. 23:14–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M,
Tan Y, Yi W, Xiao L, Li X, Huang C, Cao L, Tang K, Li X, Shen S and
Li G: Lactotransferrin: a candidate tumor suppressor, deficient
expression in human nasopharyngeal carcinoma and inhibits NPC cell
proliferation by modulating the mitogen-activated protein kinase
pathway. Int J Cancer. 123:2065–2072. 2008. View Article : Google Scholar
|
|
17
|
Krutzik PO, Irish JM, Nolan GP and Perez
OD: Analysis of protein phosphorylation and cellular signaling
events by flow cytometry: techniques and clinical applications.
Clin Immunol. 110:206–221. 2004. View Article : Google Scholar
|
|
18
|
Zhang L, Tang A, Zhou Y, Tang J, Luo Z,
Jiang C, Li X, Xiang J and Li G: Tumor-conditioned mesenchymal stem
cells display hematopoietic differentiation and diminished influx
of Ca2+. Stem Cells Dev. 21:1418–1428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li FL, Xu R, Zeng QC, Li X, Chen J, Wang
YF, Fan B, Geng L and Li B: Tanshinone IIA inhibits growth of
keratinocytes through cell cycle arrest and apoptosis: underlying
treatment mechanism of psoriasis. Evid Based Complement Alternat
Med. 2012:9276582012.PubMed/NCBI
|
|
20
|
Abou EL-Ela M, Nagui N, Mahgoub D,
El-Eishi N, Fawzy M, El-Tawdy A, Abdel Hay R and Rashed L:
Expression of cyclin D1 and p16 in psoriasis before and after
phototherapy. Clin Exp Dermatol. 35:781–785. 2010.PubMed/NCBI
|
|
21
|
Wittayarat M, Fujiwara A, Chatdarong K,
Techakumphu M, Sato Y, Tanihara F, Morita Y, Taniguchi M and Otoi
T: Cell cycle analysis and interspecies nuclear transfer of cat
cells treated with chemical inhibitors. Acta Vet Hung. 62:233–242.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mok CF, Xie CM, Sham KW, Lin ZX and Cheng
CH: 1,4-dihydroxy-2-naphthoic acid induces apoptosis in human
keratinocyte: potential application for psoriasis treatment. Evid
Based Complement Alternat Med. 2013:7928402013.PubMed/NCBI
|
|
23
|
Broshtilova V, Lozanov V and Miteva L:
Polyamine metabolism changes in psoriasis. Indian J Dermatol.
58:306–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
25
|
Zhou Y, Wang W, Zheng D, Peng S, Xiong W,
Ma J, Zeng Z, Wu M, Zhou M, Xiang J, Xiang B, Li X, Li X and Li G:
Risk of nasopharyngeal carcinoma associated with polymorphic
lactotransferrin haplotypes. Med Oncol. 29:1452–1462. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruan L, Wang GL, Chen Y, Yi H, Tang CE,
Zhang PF, Li MY, Li C, Peng F, Li JL, Chen ZC and Xiao ZQ:
Identification of tyrosine phosphoproteins in signaling pathway
triggered TGF-α by using functional proteomics technology. Med
Oncol. 27:1407–1414. 2010.PubMed/NCBI
|
|
27
|
Gunduz K, Temiz P, Gencoglan G, Inanir I
and Catalkaya A: Expression of nuclear factor kappa B and survivin
in psoriasis. ISRN Dermatol. 2012:2570592012.PubMed/NCBI
|
|
28
|
Han Y, Liu T and Lu L: Apolipoprotein E
gene polymorphism in psoriasis: a meta-analysis. Arch Med Res.
44:46–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
